Davis company working on breathable medicine to aid Covid-19 recovery

A Davis biopharmaceutical startup has licensed a breathable statin technology from the University of California Davis that may help people suffer less and recover faster from Covid-19. InVixa Inc. plans to be in preclinical trials starting this year for its breathable medicine, which gets into the nose and lungs more quickly than a pill and could treat the respiratory problems caused by viruses and specifically Covid-19. Human trials could begin this year. “Our initial focus will be to treat…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news